期刊文献+

大肠杆菌嘌呤核苷磷酸化酶基因真核表达载体的构建及其在MKN-45细胞中的表达 被引量:2

Construction of Eukaryotic Expression Vector Containing E.coli Purine Nucleoside Phosphorylase and Its Expression in MKN-45 Cells
下载PDF
导出
摘要 目的克隆大肠杆菌嘌呤核苷磷酸化酶(EPNP)基因并构建真核表达载体pcDNA3.1-EPNP,将重组质粒转染MKN-45细胞获得高表达大肠杆菌PNP基因的MKN-45细胞克隆。方法根据Gen-bank中大肠杆菌PNP基因的核苷酸序列,设计并合成了一对引物,以大肠杆菌基因组DNA为模板,进行PCR扩增,并将扩增产物定向插入pMD-18T克隆载体中进行序列测定,测序正确后将其亚克隆至表达载体pcDNA3.1,利用脂质体将重组质粒转染MKN-45细胞。结果PCR扩增出716bp大小的片段,测序结果与已报道的EPNP基因序列一致;亚克隆经酶切鉴定正确;RT-PCR证明经G418筛选得到的转基因MKN-45细胞克隆中存在大量EPNPmRNA,前体药MePdR对转染EPNP的MKN-45细胞有较强的细胞毒作用。结论成功构建了大肠杆菌PNP基因的真核表达载体,获得了稳定表达大肠杆菌PNP基因的MKN-45细胞克隆,为PNP/MepdR自杀基因系统在胃癌基因治疗中的应用奠定了良好的基础。 Objective To clone E. coil PNP gene, construct its eukaryotic expression vector and obtain positive MKN-45 cell clones expressing E. coil PNP gene stably. Methods PCR amplification was performed using primers based on E. coil PNP gene sequence from Genbank, E. coil genomic DNA as template. PCR product was inserted into pMD-18T. After the sequencing was confirmed, the gene was subcloned to pcDNA3. 1 to construct recombinant eukaryotic expression vector pcDNA3. 1-EPNP. The recombinant piasmid was transfected into MKN-45 ceils by lipofectamin method. Results PCR yielded a fragment of 716bp and EPNP was verified by sequence analysis. Enzyme digestion analysis showed that the target gene was sub cloned into recombinant vector. Resistant clones MKN-45 expressed high amounts of EPNP mRNA and showed a strong sensitivity to MePdR. Conclusion The eukaryotic expression plasmid containing E. coil PNP gene was successfully constructed. The positive MKN-45 cell clones expressing E. coil PNP gene stably were obtained, which has laid a solid ground for further study of gastric cancer gene therapy with PNP/MepdR suicide gene system.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2006年第4期239-242,共4页 Cancer Research on Prevention and Treatment
基金 吉林省科委资助项目(20030424-02)
关键词 大肠杆菌嘌呤核苷磷酸化酶 自杀基因 基因治疗 E. coli purine nucleoside phosphorylase Suicide gene Gene therapy
  • 相关文献

参考文献8

  • 1Mao C, Cook WJ, Zhou M, et al. The crystal structure of Escherichia coli purine nucleoside phosphorylase., a comparison with the human enzymereveals a conserved topology [J].Structure, 1997,5(10):1373-1383.
  • 2Sorscher EJ, Peng SY, Bebok Z, et al. et al. Tumor cell bystander killing in colonic carcinoma utilizing the E. coli DeoD gene product to generate toxic purine [J]. Proc Am Assoc Cancer research, 1994,7(4)35:229.
  • 3奥斯伯F 金斯顿RE.精编分子生物学实验指南[M].北京:科学出版社,1998.29-108.
  • 4Martiniello-Wilks R, Garcia-Aragon J, Daja MM, et al. In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus Vectors [J]. Hum Gene Ther, 1998, 9(11):1617-1626.
  • 5Huber BE, Austin EA, Richards CA, et al. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene., significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase [J]. Proc Natl Acad Sci USA, 1994, 91(17) : 8302-8306.
  • 6Hughes BW, King SA, Allan PW, et al. Cell to cell contact is not required for bystander cell killing by Eseheriehia eoli purine nueleoside phosphorylase[J]. J Biol Chem, 1998, 273(4) :2322-2328.
  • 7Krohne TU, Shankara S, Geissler M, et al. Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro[J]. Hepatolngy,2001, 34(3):511-518.
  • 8Freenab SM, Abboud CN, Whartenby KA, et al. The "bystandereffect": tumor regression when a fraction of the tumor mass is genetically modified [J]. Cancer Res, 1993, 53 (21) :5274-5283.

共引文献114

同被引文献21

  • 1郑丽端,童强松,陶凯雄,汪良,张波.稳定过表达smac基因胃癌细胞株的建立及其化疗敏感性研究[J].肿瘤防治研究,2005,32(1):18-21. 被引量:7
  • 2Maelandsmo GM,Florenes VA, Mellingsaeter T, et al. Differ ential expression patterns of S100A2, S100A4 and S100A6 dur ing progression of human malignant melanoma[J]. Int J Cancer, 1997,74(4) :464-469.
  • 3IIg EC, Schafer BW, Heizmann CW. Expression pattern of S100 calcium-binding proteins in human tumors[J]. Int J Cancer, 1996,68(8): 325-332.
  • 4Ethan DE,Leigh CM,Peter HW. S100 proteins and their influence on pro-survival pathways in cancer[J]. Bioehem Cell Biol, 2004,82 (3) : 508-515.
  • 5Golitsina NL, Kordowska J, Wang CL, et al. Ca2 +-depedent binding of calcyclin to muscle tropomyosin[J]. Biochem Biophys Res Commun, 1996,220(14) :360 365.
  • 6Filipek A,Wojda U,Lesniak W. Interaction of calcyclin and its cyanogen bromide fragments with annexin Ⅱ and glycraldehyde 3-phosphate dehydrogenase[J]. Int J Biochem Cell Biol,1995, 27(6):1123-1131.
  • 7Mani RS,McCubbin WD, Kay CM. Calcium dependent regulation of caldesmon by an 11-KDa smooth muscle calcium- binding protein, caltropiin [ J]. Biochemistry, 1992, 31 ( 2 ) : 11896-11901.
  • 8Sudo T, Hidaka H. Regulation of calcyclin (S100A6) binding by alternative splicing in the N-termina regulatory domain of annexin Ⅺ isoforms[J]. J Biol Chem, 1998, 273 ( 11 ) : 6351-6357.
  • 9Komatsu K, Andoh A, Ishiguro S, et al. Increased expression of S100A6 (Calcyclin), a calcium binding protein of the S100 family,in human colorectal adenocarcinomas[J]. Clin Cancer Res,2000,6(1 ) : 172-177.
  • 10Komatsu K, Murata K, Kameyama M, et al. Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metasta ses[J]. Oncol, 2002,63 (2) : 192-200.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部